Introducing the Pender Alternative Multi-Strategy Growth Fund, now open for investment. Ask us for more information.

Fixed Income Funds

Pender Bond Universe Fund - Q2 2025

Highlights Positive contributors were shorter-dated, higher-quality lines as well as the Fund’s exposure to credit through the Pender Corporate Bond Fund. With high-yield spreads remaining at approximately 4% at quarter-end and with indicators skewed to the likelihood of recession, the Fund’s exposure to credit remains towards the lowest since the Fund’s inception. --- For the […]

Read More
Pender Corporate Bond Fund - June 2023

Highlights Positive contributors included: Paratek Pharmaceuticals, Inc. to be acquired leading to a gain of more than 10% in that position; OPKO Health Inc. on the FDA’s approval of the company’s NGENLA growth hormone therapy; Carriage Services Inc. rallied over 5% on a takeover bid from a trade buyer; and Fannie Mae preferred shares also […]

Read More
Pender Corporate Bond Fund – May 2023

Highlights Overall, a choppy month from a combination of wider credit spreads, higher sovereign rates and uncertainty surrounding the U.S. debt ceiling. Positive contributors were Cineworld Group PLC, Paratek Pharmaceuticals Inc, and Emergent BioSolutions Inc as catalysts emerged for these severely discounted bonds. Canadian rate-reset preferreds are at levels last seen in 2016. History suggests […]

Read More
Profiles in Credit - Sabrina Fox

Geoff Castle and Parul Garg host Sabrina Fox, Founder of Fox Legal Training. The group cover Sabrina’s road to her current position and starting her company, the benefits of “speaking legalese” as well as some cautionary tales and lessons learned. And before you jump to any conclusions, if you think that a discussion of legal covenants in credit might be […]

Listen Now
Pender Corporate Bond Fund – April 2023

Highlights The strongest contributors to the Fund were Paratek Pharmaceuticals Inc., Emergent BioSolutions Inc., Esperion Therapeutics Inc., and Bausch Health. Decliners in the Fund included McDermott International Inc., PHI Group Inc., and American Tire Distributors Inc. In April, the Fund added a new position in DISH Network Corporation which is building out an ambitious 5G […]

Read More
Pender Bond Universe Fund – Q1 2023

Highlights For the three months ended March 31, 2023, the Fund generated a 1.9% return.[1] Several high-quality, defensive, relatively longer-dated lines, such as Loblaw Companies Ltd., Verisign Inc. and Bell Canada Enterprises Inc. bolstered performance. There are signs suggesting the hiking cycle is nearing its peak. Should the rate hikes to date slow the economy […]

Read More
Pender Corporate Bond Fund – March 2023

The Pender Corporate Bond Fund returned -0.5%[1] in March. Although the period was a strong one for the high-grade part of the portfolio, a few idiosyncratic events in particular lines and widening spreads in lower-tier credit holdings led to a net negative result for the month. Highlights Most of the Fund’s investment grade holdings were […]

Read More
Pender Corporate Bond Fund – February 2023

Highlights The Pender Corporate Bond Fund had a relatively strong performance amidst a market that saw larger price declines in both high yield and investment grade bond benchmarks. We added a position in the 2028 unsecured bonds of Brazilian payments processing specialist, StoneCo Ltd. An equity portfolio holding of Berkshire Hathaway Inc., the company’s bonds […]

Read More
Pender Corporate Bond Fund – January 2023

Highlights Most of the holdings of the Pender Corporate Bond Fund rose as lower benchmark yields coincided with narrowing spreads for corporate bonds. Significant performers included positions in discounted convertible bonds as holdings in Eventbrite Inc., Liberty TripAdvisor Holdings, Inc. and Esperion Therapeutics Inc. each gained in excess of 10%. New positions included recycling an […]

Read More
1 7 8 9 10 11 13

Sign Me Up

Receive a hand-picked selection of our latest insights monthly, straight to your inbox.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Email Opt In

© 2026 PenderFund Capital Management Ltd. All Rights Reserved.
crossmenuchevron-downchevron-up-circle linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram